166 related articles for article (PubMed ID: 24228403)
1. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 1) Regenerative medicine for digestive organs and kidney].
Nakauchi H
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2225-31. PubMed ID: 24228403
[No Abstract] [Full Text] [Related]
2. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 3) Regenerative medicine for neurological disorders].
Takahashi J
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2241-6. PubMed ID: 24228405
[No Abstract] [Full Text] [Related]
3. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; introduction].
Tsubouchi H; Fukuda K
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2224. PubMed ID: 24228402
[No Abstract] [Full Text] [Related]
4. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 2) Clinical application of iPS cells in cardiovascular field].
Fukuda K
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2232-40. PubMed ID: 24228404
[No Abstract] [Full Text] [Related]
5. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Frontier of the regenerative medicine; 4) Perspective on regenerative medicine for spinal cord injury using iPS cell--from bench to bedside].
Nakamura M; Okano H; Toyama Y
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2247-53. PubMed ID: 24228406
[No Abstract] [Full Text] [Related]
6. Regenerative medicine: a 2009 overview.
Andersson ER; Lendahl U
J Intern Med; 2009 Oct; 266(4):303-10. PubMed ID: 19765176
[TBL] [Abstract][Full Text] [Related]
7. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 3) iPS cell technology for neurodegenerative disease].
Inoue H
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2267-72. PubMed ID: 24228410
[No Abstract] [Full Text] [Related]
8. Creating human organs in chimaera pigs: an ethical source of immunocompatible organs?
Shaw D; Dondorp W; Geijsen N; de Wert G
J Med Ethics; 2015 Dec; 41(12):970-4. PubMed ID: 25378549
[TBL] [Abstract][Full Text] [Related]
9. Will it be possible to generate kidney tissue from induced pluripotent stem cells for regenerative therapy?
Osafune K
Regen Med; 2014 Jan; 9(1):9-12. PubMed ID: 24351001
[No Abstract] [Full Text] [Related]
10. [Frontline in the research of regenerative medicine].
Inoue H; Okano H
Rinsho Shinkeigaku; 2010 Nov; 50(11):886. PubMed ID: 21921489
[No Abstract] [Full Text] [Related]
11. Report on ISN Forefronts, Florence, Italy, 12-15 September 2013: Stem cells and kidney regeneration.
Romagnani P; Humphreys BD
Kidney Int; 2014 Jul; 86(1):23-7. PubMed ID: 24897031
[TBL] [Abstract][Full Text] [Related]
12. [Advances in kidney development and application for regenerative medicine].
Tanigawa S; Nishinakamura R
Nihon Jinzo Gakkai Shi; 2015; 57(1):233-40. PubMed ID: 25735082
[No Abstract] [Full Text] [Related]
13. Kidney bioengineering in regenerative medicine: An emerging therapy for kidney disease.
Lin YQ; Wang LR; Pan LL; Wang H; Zhu GQ; Liu WY; Wang JT; Braddock M; Zheng MH
Cytotherapy; 2016 Feb; 18(2):186-97. PubMed ID: 26596504
[TBL] [Abstract][Full Text] [Related]
14. Stem cells and regenerative medicine in domestic and companion animals: a multispecies perspective.
Gonçalves NN; Ambrósio CE; Piedrahita JA
Reprod Domest Anim; 2014 Oct; 49 Suppl 4():2-10. PubMed ID: 25277427
[TBL] [Abstract][Full Text] [Related]
15. Human induced pluripotent stem cells: A disruptive innovation.
De Vos J; Bouckenheimer J; Sansac C; Lemaître JM; Assou S
Curr Res Transl Med; 2016; 64(2):91-6. PubMed ID: 27316392
[TBL] [Abstract][Full Text] [Related]
16. Enthusiasm for induced pluripotent stem cell-based therapies in kidney regeneration.
Shen WC; Chou YH; Lin SL
J Formos Med Assoc; 2016 Aug; 115(8):593-4. PubMed ID: 25043507
[No Abstract] [Full Text] [Related]
17. [Progress in stem cells and regenerative medicine].
Wang L; Zhu H; Hao J; Zhou Q
Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):871-9. PubMed ID: 26672363
[TBL] [Abstract][Full Text] [Related]
18. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 2. Diseases originated from stem cell abnormalities; 2) Human leukemic stem cell].
Akashi K
Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2262-6. PubMed ID: 24228409
[No Abstract] [Full Text] [Related]
19. Is regenerative medicine a new hope for kidney replacement?
Nowacki M; Kloskowski T; Pokrywczyńska M; Nazarewski Ł; Jundziłł A; Pietkun K; Tyloch D; Rasmus M; Warda K; Habib SL; Drewa T
J Artif Organs; 2014 Jun; 17(2):123-34. PubMed ID: 24748421
[TBL] [Abstract][Full Text] [Related]
20. Generation of kidney from pluripotent stem cells via blastocyst complementation.
Usui J; Kobayashi T; Yamaguchi T; Knisely AS; Nishinakamura R; Nakauchi H
Am J Pathol; 2012 Jun; 180(6):2417-26. PubMed ID: 22507837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
